About Nerva
Nerva is a Healthcare company based in Cremorne (Australia). Digital therapeutics are provided for IBS and other health conditions. It operates on a Subscription Services and HealthTech model. Nerva has raised $61 million across 2 funding rounds from investors including MainStreet Advisors, JAZZ Venture Partners and B-FLEXION. Nerva has completed 1 acquisition, including Cara Care. Nerva offers products and services including Nerva Program, Claria, Relio, Evia, and Finito. Its focus areas include Digital Health and Digital Therapeutics.
Company details
Digital therapeutic solutions are developed by Nerva under Mindset Health for managing irritable bowel syndrome (IBS) and other conditions like mental health, chronic back pain, menopause, and smoking cessation. The primary focus is placed on brain-gut therapy for IBS through personalized, AI-enhanced programs. Services are extended to clinicians and health plans, with research-backed approaches targeting various health sectors. Accessibility and user support are emphasized with daily audio sessions and real-person customer service.
- Total Equity Funding$61M (USD)
in 2 rounds
- Latest Funding Round$61M (USD), Series B
Aug 2021
- InvestorsMainStreet Advisors
& 4 more
- Investments & Acquisitions
Products & Services of Nerva
Nerva offers a comprehensive portfolio of products and services, including Nerva Program, Claria, Relio, Evia, and Finito.
Gut-directed hypnotherapy is offered for IBS symptom management.
Mental health support is provided through digital therapeutic tools.
Chronic back pain management is facilitated via digital therapy.
Menopause symptoms are addressed with digital therapeutic solutions.
Smoking cessation support is delivered through digital therapy tools.
Funding Insights of Nerva
Nerva has successfully raised a total of $61M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $61 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61M
- Total Rounds 2
- Last Round Series B — $61M
- Investors Count 5
All 2 funding rounds of Nerva with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2021 | $61M | Series B | – | JAZZ Venture Partners, Gurnet Point Capital | |
| Jun 2018 | Seed | – | – |
5 investors in total: 5 institutional.
Investors in Nerva
Nerva has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include MainStreet Advisors, JAZZ Venture Partners and B-FLEXION.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life Science focused VC firm investing in the US | jazzvp.com | San Francisco, United States | ||
Investment partnerships are built and principal investments are made by B-FLEXION. | gurnetpointcapital.com | |||
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
Investment consulting firm | 2003 | mainstreetadv.com | Chicago, United States | |
KKCG is engaged in investment and innovation across multiple industries. | kkcg.com | Lucerne, Switzerland |
Investor details for Nerva
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nerva
2 people are tracked at Nerva (2 in leadership).
| Name | Role | Group |
|---|---|---|
Simon Levy | CEO & co-founder | Leadership |
Bruce Erickson | Director of Engineering - Backend | Leadership |
Complete people profiles for Nerva
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nerva
Nerva has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cara Care.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of an app for monitoring gut health | cara.care | Hamburg, Germany | 2016 | Mar 2024 | •••• |
Complete acquisition details for Nerva
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nerva
3 dated milestones of Nerva across 6 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round.
- Funding Latest funding round, Series B, of $61.0M.
- Acquisition Acquires Cara Care.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nerva
Nerva is headquartered in Cremorne, Australia. It is registered at Cremorne, New South Wales, Australia.
Nerva is a funded company, having raised a total of $61M across 2 funding rounds to date.
Digital therapeutic solutions are developed by Nerva under Mindset Health for managing irritable bowel syndrome (IBS) and other conditions like mental health, chronic back pain, menopause, and smoking cessation. The primary focus is placed on brain-gut therapy for IBS through personalized, AI-enhanced programs. Services are extended to clinicians and health plans, with research-backed approaches targeting various health sectors. Accessibility and user support are emphasized with daily audio sessions and real-person customer service.
Nerva offers Nerva Program, Claria, Relio, Evia, and Finito.
Nerva has made 1 acquisition, including Cara Care.
Nerva has 5 investors. Key investors include MainStreet Advisors, JAZZ Venture Partners, B-FLEXION, KKCG, and Lux Capital.